<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04859049</url>
  </required_header>
  <id_info>
    <org_study_id>anesth RIO</org_study_id>
    <nct_id>NCT04859049</nct_id>
  </id_info>
  <brief_title>Single Injection Infromedial Peribulbar Injection in Lacrimal Duct</brief_title>
  <official_title>Assessing the Effect of Single Injection Infromedial Peribulbar Injection in Lacrimal Duct Intubation Surgery in Adult Patient: Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Research Institute of Ophthalmology, Egypt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Research Institute of Ophthalmology, Egypt</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      infromedial injection of 3 ml local anesthetic drugs and assessing the pain during lacrimal&#xD;
      duct intubation and probability of false tracking&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the OR; we will insert a 22G venous cannula and connect the patient to the monitor (pulse&#xD;
      oximeter, ECG and NIBP).&#xD;
&#xD;
      We will insert a 25G needle inferior to the lower lid punctum and inject 3 ml of our local&#xD;
      anesthetic mixture (xylocaine 2% +Bupivacaine 0.5%+45IU hyaluronidase enzyme)&#xD;
&#xD;
      During surgery, we will assess the pain degree during probing using Verbal Rating Scale (0 to&#xD;
      10 scale where 0 is no pain an 10 is unbearable pain), to assess the efficiency of this&#xD;
      single low volume injection.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 4, 2021</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Verbal rating scale VRS</measure>
    <time_frame>jan 2021 to july 2021</time_frame>
    <description>pain scale</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pain Due to Certain Specified Procedures</condition>
  <arm_group>
    <arm_group_label>infromedial single injection</arm_group_label>
    <description>adult patient ASA 1&amp; 2</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>infromedial single injection</intervention_name>
    <description>only single needle entry &amp; injection to have anesthesia done</description>
    <arm_group_label>infromedial single injection</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        a group of 30 adult patients (ASA 1 &amp; 2)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adults undergoing lacrimal duct intubation surgery&#xD;
&#xD;
          -  ASA 1&amp; 2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient refusal&#xD;
&#xD;
          -  INR more than 2&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>abeer salem, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>research institute of ophthalmology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Institute of Ophthamology</name>
      <address>
        <city>Giza</city>
        <zip>12573</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 4, 2021</study_first_submitted>
  <study_first_submitted_qc>April 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2021</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Research Institute of Ophthalmology, Egypt</investigator_affiliation>
    <investigator_full_name>Abeer Samir Salem</investigator_full_name>
    <investigator_title>Researcher of anesthesia</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

